Evidence map›Paper›PMID 25333702›Full record

ArticlePloS one2014

TGFβ-induced deptor suppression recruits mTORC1 and not mTORC2 to enhance collagen I (α2) gene expression.

Falguni Das, Amit Bera, Nandini Ghosh-Choudhury, Hanna E Abboud, Balakuntalam S Kasinath, Goutam Ghosh Choudhury

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Inhibition of HIF-1α Attenuates Silica-Induced Pulmonary Fibrosis.International journal of environmental research and public health · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2020
    Article
  12. Review
  13. Article
  14. Deciphering the SUMO code in the kidney.Journal of cellular and molecular medicine · 2019
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Falguni DasDepartments of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Amit BeraDepartments of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Nandini Ghosh-ChoudhuryDepartment of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America; VA Research, South Texas Veterans Health Care System, San Antonio, Texas, United States of America.
Hanna E AbboudDepartments of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America; VA Research, South Texas Veterans Health Care System, San Antonio, Texas, United States of America.
Balakuntalam S KasinathDepartments of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America; VA Research, South Texas Veterans Health Care System, San Antonio, Texas, United States of America.
Goutam Ghosh ChoudhuryDepartments of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America; Geriatric Research, Education and Clinical Center, South Texas Veterans Health Care System, San Antonio, Texas, United States of America; VA Research, South Texas Veterans Health Care System, San Antonio, Texas, United States of America.
South Texas Veterans Health Care System · USThe University of Texas Health Science Center at San Antonio · US

Funding

Mechanism of Renal Cell Injury in DiabetesR01DK050190 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GHOSH CHOUDHURY, GOUTAM · 2004 to 2013
$2.3M
BLRD VA I01 BX000926NIDDK NIH HHS R01 DK050190NIDDK NIH HHS R01 DK50190
6 · The paper itself

Abstract

Enhanced TGFβ activity contributes to the accumulation of matrix proteins including collagen I (α2) by proximal tubular epithelial cells in progressive kidney disease. Although TGFβ rapidly activates its canonical Smad signaling pathway, it also recruits noncanonical pathway involving mTOR kinase to regulate renal matrix expansion. The mechanism by which chronic TGFβ treatment maintains increased mTOR activity to induce the matrix protein collagen I (α2) expression is not known. Deptor is an mTOR interacting protein that suppresses mTOR activity in both mTORC1 and mTORC2. In proximal tubular epithelial cells, TGFβ reduced deptor levels in a time-dependent manner with concomitant increase in both mTORC1 and mTORC2 activities. Expression of deptor abrogated activity of mTORC1 and mTORC2, resulting in inhibition of collagen I (α2) mRNA and protein expression via transcriptional mechanism. In contrast, neutralization of endogenous deptor by shRNAs increased activity of both mTOR complexes and expression of collagen I (α2) similar to TGFβ treatment. Importantly, downregulation of deptor by TGFβ increased the expression of Hif1α by increasing translation of its mRNA. TGFβ-induced deptor downregulation promotes Hif1α binding to its cognate hypoxia responsive element in the collagen I (α2) gene to control its protein expression via direct transcriptional mechanism. Interestingly, knockdown of raptor to specifically block mTORC1 activity significantly inhibited expression of collagen I (α2) and Hif1α while inhibition of rictor to prevent selectively mTORC2 activation did not have any effect. Critically, our data provide evidence for the requirement of TGFβ-activated mTORC1 only by deptor downregulation, which dominates upon the bystander mTORC2 activity for enhanced expression of collagen I (α2). Our results also suggest the presence of a safeguard mechanism involving deptor-mediated suppression of mTORC1 activity against developing TGFβ-induced renal fibrosis.

Indexed as

AnimalsCell LineCollagen Type IDown-RegulationEpithelial CellsGene ExpressionHumansHypoxia-Inducible Factor 1, alpha SubunitIntracellular Signaling Peptides and ProteinsKidney Tubules, ProximalMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MiceMultiprotein ComplexesSignal TransductionTOR Serine-Threonine KinasesCollagen Type IDEPTOR protein, humanHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitIntracellular Signaling Peptides and ProteinsMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Multiprotein ComplexesTOR Serine-Threonine KinasesTransforming Growth Factor beta1

Identifiers

PMID25333702
PMCPMC4198127
OpenAlexW2011736975

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.